The Role of Centaurin-α1 in Alzheimer’s Disease Pathology
Principal Investigator
Ryohei Yasuda, PhD
Max Planck Florida Institute for Neuroscience
Jupiter, FL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$250,000
Active Dates
July 01, 2015 - June 30, 2018
Grant ID
A2015251S
Summary
It is thought that Alzheimer’s disease is caused by accumulation of ß-Amyloid. We recently identified that a signaling protein called centaurin-a1 (CentA1) causes ß-Amyloid-induced dysfunction of neurons and thus potentially contributes to brain dysfunction in Alzheimer’s disease. In this project, we will further study the potential roles of CentA1 in Alzheimer’s disease using newly developed CentA1 knockout mice in combination with the model mice for Alzheimer’s disease. We hope that this will lead to new therapeutics targeting CentA1.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD